The company
Insmed Incorporated
INSM · Nasdaq
INSM stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 34 weeks. It is 19.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 34
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $289.9M
- Officials’ trades on record
- 11
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
11 disclosed lines: House 10, Senate 0, executive 1; 3 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 10 Jun 2026filed 7 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 28 Apr 2026filed 1 Jul 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 3 Oct 2025filed 18 Nov 2025 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 22 Sep 2025filed 10 Oct 2025 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 8 Aug 2025filed 12 Sep 2025 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | sold | $1k–$15k | 7 Jul 2025filed 14 Aug 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 16 Jun 2025filed 16 Jul 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 9 Apr 2025filed 14 May 2025 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 21 Jun 2024filed 9 Jul 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | soldjoint | $1k–$15k | 28 May 2024filed 8 Jun 2024 |
| Josh Gottheimer House: U.S. House ClerkNJ05 | boughtjoint | $1k–$15k | 6 Dec 2022filed 13 Jan 2023 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| David R. BrennanDirector | sold | 25,000at $124.00 | 9 Sep 2026filed 11 Sep 2026 |
| Melvin Md SharokyDirector | sold | 5,000at $127.53 | 17 Aug 2026filed 19 Aug 2026 |
| Roger AdsettChief Operating Officer | sold | 239,850at $133.27 | 10 Aug 2026filed 12 Aug 2026 |
| Martina M.d. FlammerChief Medical Officer | sold | 8,895at $127.00 | 6 Aug 2026filed 7 Aug 2026 |
| Martina M.d. FlammerChief Medical Officer | sold | 18,278at $129.40 | 6 Aug 2026filed 7 Aug 2026 |
| William LewisChair and CEO | sold | 4,828at $105.62 | 23 Jul 2026filed 24 Jul 2026 |
| William LewisChair and CEO | sold | 5,872at $106.43 | 23 Jul 2026filed 24 Jul 2026 |
| William LewisChair and CEO | sold | 5,005at $116.55 | 9 Jul 2026filed 10 Jul 2026 |
| William LewisChair and CEO | sold | 2,335at $117.62 | 9 Jul 2026filed 10 Jul 2026 |
| William LewisChair and CEO | sold | 3,359at $118.52 | 9 Jul 2026filed 10 Jul 2026 |
| Martina M.d. FlammerChief Medical Officer | sold | 4,854at $109.02 | 6 Jul 2026filed 8 Jul 2026 |
| Martina M.d. FlammerChief Medical Officer | sold | 7,448at $110.60 | 6 Jul 2026filed 8 Jul 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.